Only generic versions of Lupron (leuprolide) are available, as the brand-name form is no longer manufactured. These generic medications are only available in one form and strength: Leuprolide 1 mg per 0.2 mL injection. Sandoz and Teva Pharmaceuticals are some of the companies that manufacture a generic version. The FDA has determined that these generics are as good as brand-name Lupron.
Lupron® (leuprolide acetate) is a prescription medication approved for use in advanced prostate cancer and to temporarily stop puberty in children who are starting puberty too early. It is given via a daily subcutaneous injection (an injection into the layer of tissue just beneath the skin).
Lupron was originally manufactured by Abbott Laboratories. However, it is no longer available as a brand-name medication. Generic versions are available.
Generic Lupron is available in one form and strength: Leuprolide 1 mg per 0.2 mL injection.
Generic Lupron is made by a few different companies, including:
- Sun Pharmaceutical Industries, Inc.
- Teva Pharmaceuticals.
All generic medications must undergo certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generics are equivalent to the brand-name medications and assigns each generic a rating. An "AP" rating means that the FDA has determined that a generic injectable medication is equivalent to a brand-name medication.
All of the generic versions of Lupron currently available have an "AP" rating, which means that they should be equivalent to Lupron.
However, generic medications are allowed to have different inactive ingredients than the brand-name medication. This might include fillers, dyes, or other ingredients that may cause problems for people with allergies or sensitivities.